An Experiment Comparing Public Reactions to the Labels "Community Immunity" Versus "Herd Immunity".
ConditionAttitudes
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLaval University
About this trial
Participants are shown a scenario consisting of static images from a previous study ("herdimm") showing a visualization of how herd immunity works. Participants are randomized to see the text with the term "herd immunity" or "community immunity."
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Able to use a computer
Able to use the internet
Able to read and respond to questions in English or French
18+ years old and living in Canada
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Using the term "community immunity" instead of "herd immunity"
BehavioralIn the intervention arm, participants are shown the less traditional term "community immunity" in place of the more traditional "herd immunity"
Herd immunity
BehavioralUsing the traditional term "herd immunity"
Treatment groups
350 Participants
are divided into 2 treatment groupsGroup A: Herd immunityPlacebo comparator 1 intervention
Group B: Community immunityExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Orientation towards protection of others
A measure of the extent to which people believe that individual vaccination behavior is important to protect others. Question wording: "When a safe and effective vaccine exists that can prevent people from catching and passing on a contagious disease, it is important for people to get vaccinated to protect ..." Measured across two to three items (family, others in the community, people who are more vulnerable to disease) on a 7-point Likert-type scale (strongly disagree = 1, strongly agree = 7).
Time frame
Immediately after the interventionLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: